Header Image

Investor Relations

Investor Relations

Investor Relations

Corporate Profile

Welcome! Whether you are a potential investor in BioCryst Pharmaceuticals or you are already a shareholder, our investor center is the primary source of information about the company. Just choose a topic, or if you have a question, email us.

$6.99 + 0.75
Mar 1, 2017 at 12:33 PM ET
Intraday data provided by eSignal


Feb 27, 2017
RESEARCH TRIANGLE PARK, N.C., Feb. 27, 2017 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) announced today financial results for the fourth quarter and full yea...
Read More
Feb 27, 2017
Reduction of 63% in overall attack rate in HAE patients with severe disease (p=0.006) RESEARCH TRIANGLE PARK, N.C., Feb. 27, 2017 (GLOBE NEWSWIRE) -- BioCryst Pharmaceutica...
Read More

Investor Relations

Rob Bennett, Vice President Investor Relations & Operations

Proxy Online

For more information click here.

Stockholder Services

Questions about stock transfers and lost certificates should be directed to the transfer agent:
American Stock Transfer & Trust Company
59 Maiden Lane
New York, NY 10038
1-800-937-5449 (toll free in US and Canada)
1-718-921-8200 (callers outside the US and Canada)